Lucence INSIGHT™ is a multi-cancer early detection test that utilizes next-generation sequencing (NGS) technology for blood testing. This test can screen for multiple high-incidence and high-risk cancers simultaneously from a single blood draw, including lung cancer, breast cancer, colorectal cancer, prostate cancer, liver cancer, nasopharyngeal cancer, bile duct cancer, and pancreatic cancer.
Suitable For:
- Individuals aged 40 and above who are not pregnant and without a history of cancer in the past 3 years.
-
Individuals with an elevated risk of cancer (e.g. family history of cancer, diet, lifestyle etc).
Description
Lucence INSIGHT™ 50 Multi-cancer early detection (MCED) next generation sequencing test that screens for the signal of up to 50 cancers in one simple blood draw. The test uses Lucence’s amplicon-based mirror barcoding technology to detect circulating tumor and viral DNA. It then predicts tumor location with machine learning. Screens For Cancer With High Accuracy. Screens for cancer with low false-positives.
Lucence INSIGHT™ 50 Based on our proprietary next-generation sequencing technology, it screens for the signal of cancer with a sensitivity of 80.9% and a specificity of 99%. Reported 100% positive predictive value (PPV) from a prospective real-world cohort of 264 asymptomatic individuals in 2023.3 A performance of 81% sensitivity and 99% specificity was reported from a retrospective cohort of 601 patient samples in 2024.1
LucenceINSIGHT™ 50 is recommended in conjunction with existing screening tools for: Individuals aged 40 and above who are not pregnant and without a history of cancer in the past 3 years. Individuals with an elevated risk of cancer (e.g. family history of cancer, diet, lifestyle etc).
Other Product Fact
Location
Humansa | Victoria Dockside
Address: Unit 1801, L18, K11 ATELIER Victoria Dockside, 18 Salisbury Road, Tsim Sha Tsui, Kowloon, Hong Kong
Opening hour
- Monday to Friday: 08:30 - 17:30
- Saturday: 08:30 - 13:00
- Sunday & Public Holiday: Closed
Terms & Conditions
- This package is valid from 20 November 2024 until 31 December 2024.
- Advanced booking would be required at least two (2) working days before the scheduled appointment.
- Re-scheduling or booking cancellation should be made at least two (2) working days before the appointment.
- Humansa reserves the right to amend these terms and conditions without prior notice. In the event of disputes, Humansa shall reserve the right of final and conclusive decision.
